We are exploring a new treatment using CRISPR to modify immune cells for patients with metastatic melanoma. This study aims to see if it can improve the effectiveness of cancer therapy.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced melanoma refers to malignant melanoma that has progressed to stage III or IV, meaning it has spread to nearby lymph nodes or other parts of the body. Patients may experience symptoms such as changes in existing moles, new growths on the skin, or systemic symptoms like fatigue and weight loss.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.